Effect of Sotrovimab on Hospitalization or Death Among High-risk Patients With Mild to Moderate COVID-19
JAMA (2022) - Comments
doi: 10.1001/jama.2022.2832  issn: 0098-7484  pubmed: 35285853  issn: 1538-3598 

Anil Gupta, Yaneicy Gonzalez-Rojas, Erick Juarez, Manuel Crespo Casal, Jaynier Moya, Diego Rodrigues Falci, Elias Sarkis, Joel Solis, Hanzhe Zheng, Nicola Scott, Andrea L. Cathcart, Sergio Parra, Jennifer E. Sager, Daren Austin, Amanda Peppercorn, Elizabeth Alexander, Wendy W. Yeh, Cynthia Brinson, Melissa Aldinger, Adrienne E. Shapiro